https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-03-22 / Exp. Cell Res. 2017 05;354(2):112-121
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-03-22 / Exp. Cell Res. 2017 05;354(2):112-1212017-03-22 00:00:002019-02-15 08:39:30Temperature induces significant changes in both glycolytic reserve and mitochondrial spare respiratory capacity in colorectal cancer cell lines
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2017-02-02 / Int J Hyperthermia 2017 Feb;:1-9
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2017-02-02 / Int J Hyperthermia 2017 Feb;:1-92017-02-02 00:00:002019-02-15 08:39:29Short-course preoperative radiotherapy combined with chemotherapy, delayed surgery and local hyperthermia for rectal cancer: a phase II study
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):64
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-08-24 / J. Biomed. Sci. 2016 Aug;23(1):642016-08-24 00:00:002019-02-15 08:39:07A phase I clinical study of immunotherapy for advanced colorectal cancers using carcinoembryonic antigen-pulsed dendritic cells mixed with tetanus toxoid and subsequent IL-2 treatment
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-07-19 / Clin. Cancer Res. 2017 Jan;23(2):399-406
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-07-19 / Clin. Cancer Res. 2017 Jan;23(2):399-4062016-07-19 00:00:002019-02-15 08:39:09PI3K/Akt/mTOR Signaling and Plasma Membrane Proteins Are Implicated in Responsiveness to Adjuvant Dendritic Cell Vaccination for Metastatic Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-05-14 / Cancers (Basel) 2016 May;8(5)
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-05-14 / Cancers (Basel) 2016 May;8(5)2016-05-14 00:00:002019-02-15 08:39:28In Hyperthermia Increased ERK and WNT Signaling Suppress Colorectal Cancer Cell Growth
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-05-07 / World J. Gastroenterol. 2016 May;22(17):4275-86
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-05-07 / World J. Gastroenterol. 2016 May;22(17):4275-862016-05-07 00:00:002019-02-15 08:39:08Dendritic cell-based cancer immunotherapy for colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-03-30 / Radiat Oncol J 2016 Mar;34(1):34-44
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-03-30 / Radiat Oncol J 2016 Mar;34(1):34-442016-03-30 00:00:002019-02-15 08:39:27Prospective phase II trial of regional hyperthermia and whole liver irradiation for numerous chemorefractory liver metastases from colorectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2016-01-11 / Int J Hyperthermia 2016;32(2):187-92
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2016-01-11 / Int J Hyperthermia 2016;32(2):187-922016-01-11 00:00:002019-02-15 08:39:26Long-term local control and survival after preoperative radiochemotherapy in combination with deep regional hyperthermia in locally advanced rectal cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-18
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-12-11 / Vaccines (Basel) 2015 Dec;3(4):1004-182015-12-11 00:00:002019-02-15 08:39:04Dendritic Cell-Based Adjuvant Vaccination Targeting Wilms‘ Tumor 1 in Patients with Advanced Colorectal Cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2015-10-09 / Cytotherapy 2015 Dec;17(12):1746-62
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2015-10-09 / Cytotherapy 2015 Dec;17(12):1746-622015-10-09 00:00:002019-02-15 08:38:59Validity of combination active specific immunotherapy for colorectal cancer: a meta-analysis of 2993 patients
